Vytorin

DRUG8 trials

Sponsors

Organon and Co, Bronx VA Medical Center, Baylor College of Medicine, University at Buffalo, University of Miami

Conditions

Alopecia AreataHypercholesterolemiaHyperlipidemiaInflammationMetabolic SyndromeProstate Cancer

Phase 1

Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)

CompletedNCT00652431

Organon and CoHypercholesterolemia, Hyperlipidemia

Start: 2007-05-31End: 2007-07-31Updated: 2022-02-16

Vytorin in the Treatment of Alopecia Areata

CompletedNCT01520077

University of MiamiAlopecia Areata

Start: 2011-07-31End: 2015-01-31Updated: 2015-03-17

Phase 2

Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer

RecruitingNCT06437574

Cedars-Sinai Medical CenterProstate Cancer

Start: 2024-07-16End: 2028-05-31Target: 140Updated: 2026-03-11

Phase 4

Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol

CompletedNCT00762164

Bronx VA Medical CenterHypercholesterolemia

Start: 2007-03-31End: 2009-05-31Updated: 2013-07-03

Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.

CompletedNCT00988364

Baylor College of MedicineMetabolic Syndrome

Start: 2007-03-31End: 2008-02-29Updated: 2023-11-30

Vascular and Metabolic Effects of Vytorin

CompletedNCT01660945

Gachon University Gil Medical CenterHypercholesterolemia

Start: 2011-07-31End: 2012-11-30Updated: 2014-11-04

Vascular and Metabolic Effects of Vytorin vs Simvastatin

CompletedNCT01666067

Gachon University Gil Medical CenterHypercholesterolemia

Start: 2011-11-30End: 2012-11-30Updated: 2014-11-04

Unknown Phase

To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

CompletedNCT01420328

University at BuffaloInflammation

Start: 2011-05-01End: 2016-07-01Updated: 2024-04-17